Circulation of pathogenic and multidrug resistant Escherichia coli in animals
致病性和多重耐药性大肠杆菌在动物体内的循环
基本信息
- 批准号:RGPIN-2018-06560
- 负责人:
- 金额:$ 2.4万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Escherichia coli are common bacteria in the intestinal microbiota, and include a broad variety of different clones, ranging from highly pathogenic E. coli causing severe disease in animals to non-pathogenic commensal E. coli. A high prevalence of antimicrobial resistance has been found in pathogenic and commensal E. coli isolates. Presently, both the pig and poultry industries are at a crossroad, with few alternatives for treatment of the resulting almost epidemic E. coli infections. However, little is known of how these strains are able to succeed in emerging and spreading and what bacterial or other factors may influence this.
The overall goal of this research program is to investigate the spatio-temporal spread of antimicrobial resistant and pathogenic E. coli in pigs and poultry on-farm and to identify risk factors influencing this spread. We are using two models to help achieve this goal. 1- Withdrawal by the poultry industry of systematic administration of an antimicrobial to all chicks prior to hatching and 2-Emergence and epidemic spread of highly pathogenic and extensively drug resistant E. coli strains in pigs where preventive antimicrobial medication is used after weaning.
In both models, a similar approach will be used for the characterization of E. coli isolates in order to investigate the mechanisms of emergence or disappearance of new extensively drug resistant clones and the relative role of clones and plasmids in the spread of antimicrobial resistance and virulence. The E. coli virulence and antimicrobial resistance gene profiles of isolates will be screened following whole genome sequencing and a more complete clonal analysis by whole genome phylogenetic approaches.
A novel aspect of this research is that we have first-hand models using a real situation in which bacterial virulence and multidrug resistance are coming together to create a crisis situation. This research will improve our knowledge of how high-risk clones can emerge, circulate, and contribute to increasing the spread of antimicrobial resistance. It will shed some light on how to «manage» production animals in order to reduce the spread of antimicrobial resistance to acceptable levels, allowing the continued judicious use of key antimicrobials and reducing the risk of transmission of antimicrobial resistance determinants to humans.
大肠杆菌是肠道微生物群中常见的细菌,包括各种不同的克隆,从高致病性大肠杆菌,大肠杆菌引起的动物严重疾病的非致病性大肠杆菌。杆菌致病性大肠埃希菌和非致病性大肠埃希菌的耐药率较高。大肠杆菌分离株。目前,养猪业和家禽业都处于十字路口,几乎没有其他方法来治疗由此产生的流行性大肠杆菌。大肠杆菌感染。然而,很少有人知道这些菌株是如何成功地出现和传播的,以及什么细菌或其他因素可能会影响这一点。
本研究的总体目标是调查耐药和致病性大肠埃希菌的时空传播。本研究旨在评估农场内猪只及家禽的大肠杆菌感染情况,并找出影响这种传播的风险因素。我们正在使用两种模式来帮助实现这一目标。1-家禽业在孵化前对所有雏鸡系统地施用抗菌剂,2-高致病性和广泛耐药的大肠杆菌的出现和流行传播。在断奶后使用预防性抗菌药物的猪中存在大肠杆菌菌株。
在这两种模型中,将使用类似的方法来表征E。大肠杆菌分离株,以研究新的广泛耐药克隆的出现或消失的机制,以及克隆和质粒在抗生素耐药性和毒力传播中的相对作用。急诊通过全基因组测序和全基因组系统发育分析,筛选分离株的大肠杆菌毒力和耐药性基因谱。
这项研究的一个新的方面是,我们有第一手的模型,使用一个真实的情况下,细菌的毒力和多药耐药性走到一起,创造一个危机的情况。这项研究将提高我们对高风险克隆如何出现,传播和促进抗生素耐药性传播的认识。它将阐明如何“管理”生产动物,以将抗生素耐药性的传播减少到可接受的水平,允许继续明智地使用关键抗生素,并降低将抗生素耐药性决定因素传播给人类的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fairbrother, John其他文献
Fairbrother, John的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fairbrother, John', 18)}}的其他基金
Circulation of pathogenic and multidrug resistant Escherichia coli in animals
致病性和多重耐药性大肠杆菌在动物体内的循环
- 批准号:
RGPIN-2018-06560 - 财政年份:2022
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Circulation of pathogenic and multidrug resistant Escherichia coli in animals
致病性和多重耐药性大肠杆菌在动物体内的循环
- 批准号:
RGPIN-2018-06560 - 财政年份:2021
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Circulation of pathogenic and multidrug resistant Escherichia coli in animals
致病性和多重耐药性大肠杆菌在动物体内的循环
- 批准号:
RGPIN-2018-06560 - 财政年份:2019
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Circulation of pathogenic and multidrug resistant Escherichia coli in animals
致病性和多重耐药性大肠杆菌在动物体内的循环
- 批准号:
RGPIN-2018-06560 - 财政年份:2018
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host, environmental, and bacterial factors associated with animal pathogenic and zoonotic Escherichia coli infections
与动物致病性和人畜共患大肠杆菌感染相关的宿主、环境和细菌因素
- 批准号:
2294-2010 - 财政年份:2010
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2009
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2008
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2007
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2006
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2005
- 资助金额:
$ 2.4万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
- 批准号:82371255
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
CD8+T细胞亚群在抗MDA5抗体阳性皮肌炎中的致病机制研究
- 批准号:82371805
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
- 批准号:82371711
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial Communities
单一栽培和微生物群落中铜绿假单胞菌抗生素持久性的分子机制
- 批准号:
10749974 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
仿生巨噬细胞膜包被的纳米海绵:一种治疗多重耐药铜绿假单胞菌和鲍曼不动杆菌医院相关肺炎的新疗法
- 批准号:
10674406 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
Treatment of Multidrug-Resistant Staphylococcus aureus Orthopaedic-Device Related Biofilm Infections with Local Delivery of Lytic Bacteriophage
通过局部递送裂解性噬菌体治疗多重耐药金黄色葡萄球菌骨科器械相关生物膜感染
- 批准号:
10649057 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
An intranasal room stable vaccine formulation to prevent Pseudomonas aeruginosa (R21AI169691)
用于预防铜绿假单胞菌的鼻内室内稳定疫苗制剂 (R21AI169691)
- 批准号:
10741018 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
Novel Antibiofilm Treatments for Pseudomonas aeruginosa Infection
治疗铜绿假单胞菌感染的新型抗菌膜疗法
- 批准号:
10648172 - 财政年份:2023
- 资助金额:
$ 2.4万 - 项目类别:
Operationalizing wastewater-based surveillance of multidrug-resistant bacteria
实施基于废水的多重耐药细菌监测
- 批准号:
10449747 - 财政年份:2022
- 资助金额:
$ 2.4万 - 项目类别:
Development of Broad-Spectrum Cyclic Amphiphilic Peptides against Multidrug-Resistant Bacteria
抗多重耐药细菌的广谱环状两亲肽的开发
- 批准号:
10685928 - 财政年份:2022
- 资助金额:
$ 2.4万 - 项目类别:
Development of immunotherapeutic strategies and vaccines against multidrug resistant C. auris disseminated infection
针对多重耐药耳念珠菌播散性感染的免疫治疗策略和疫苗的开发
- 批准号:
10433683 - 财政年份:2022
- 资助金额:
$ 2.4万 - 项目类别: